These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Sticholysins I and II interaction with cationic micelles promotes toxins' conformational changes and enhanced hemolytic activity. Lanio ME; Alvarez C; Ochoa C; Ros U; Pazos F; Martínez D; Tejuca M; Eugenio LM; Casallanovo F; Dyszy FH; Schreier S; Lissi E Toxicon; 2007 Nov; 50(6):731-9. PubMed ID: 17681582 [TBL] [Abstract][Full Text] [Related]
6. Stycholysin II, a cytolysin from the sea anemone Stichodactyla helianthus promotes higher hemolysis in aged red blood cells. Celedón G; González G; Barrientos D; Pino J; Venegas F; Lissi EA; Soto C; Martinez D; Alvarez C; Lanio ME Toxicon; 2008 Jun; 51(8):1383-90. PubMed ID: 18423792 [TBL] [Abstract][Full Text] [Related]
7. A new cytolytic protein from the sea anemone Urticina crassicornis that binds to cholesterol- and sphingomyelin-rich membranes. Razpotnik A; Krizaj I; Kem WR; Macek P; Turk T Toxicon; 2009 Jun; 53(7-8):762-9. PubMed ID: 19232528 [TBL] [Abstract][Full Text] [Related]
8. Avidin-FITC topological studies with three cysteine mutants of equinatoxin II, a sea anemone pore-forming protein. Anderluh G; Barlic A; Krizaj I; Menestrina G; Gubensĕk F; Macek P Biochem Biophys Res Commun; 1998 Jan; 242(1):187-90. PubMed ID: 9439633 [TBL] [Abstract][Full Text] [Related]
9. Sea anemone cytolysins as toxic components of immunotoxins. Tejuca M; Anderluh G; Dalla Serra M Toxicon; 2009 Dec; 54(8):1206-14. PubMed ID: 19268683 [TBL] [Abstract][Full Text] [Related]
10. Cell-specific enhancement of doxorubicin toxicity in human tumour cells by docosahexaenoic acid. Rudra PK; Krokan HE Anticancer Res; 2001; 21(1A):29-38. PubMed ID: 11299749 [TBL] [Abstract][Full Text] [Related]
11. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Opel D; Westhoff MA; Bender A; Braun V; Debatin KM; Fulda S Cancer Res; 2008 Aug; 68(15):6271-80. PubMed ID: 18676851 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of haemolytic activity of sea anemone cytolysins by 8-anilino-1-naphthalenesulphonate. Khoo HE; Fong CL; Yuen R; Chen D Biochem Biophys Res Commun; 1997 Mar; 232(2):422-6. PubMed ID: 9125194 [TBL] [Abstract][Full Text] [Related]
13. A multigene family of Heteractis magnificalysins (HMgs). Wang Y; Yap LL; Chua KL; Khoo HE Toxicon; 2008 Jun; 51(8):1374-82. PubMed ID: 18423794 [TBL] [Abstract][Full Text] [Related]
14. [Potentiation of the cytotoxic effects of various anticancer drugs by interferon on human neoplastic cells (HeLa) in culture]. Namba M; Yamamoto S; Tanaka H; Kanamori T; Nobuhara M; Kimoto T Gan To Kagaku Ryoho; 1983 May; 10(5):1308-12. PubMed ID: 6191681 [TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines. Kars MD; Işeri OD; Gunduz U; Molnar J Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of the third-generation bisphosphonate risedronate alone and in combination with anticancer drugs against osteosarcoma cell lines. Murayama T; Kawasoe Y; Yamashita Y; Ueno Y; Minami S; Yokouchi M; Komiya S Anticancer Res; 2008; 28(4B):2147-54. PubMed ID: 18751388 [TBL] [Abstract][Full Text] [Related]
17. Validation of a mutant of the pore-forming toxin sticholysin-I for the construction of proteinase-activated immunotoxins. Pentón D; Pérez-Barzaga V; Díaz I; Reytor ML; Campos J; Fando R; Calvo L; Cilli EM; Morera V; Castellanos-Serra LR; Pazos F; Lanio ME; Alvarez C; Pons T; Tejuca M Protein Eng Des Sel; 2011 Jun; 24(6):485-93. PubMed ID: 21296830 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of small globular protein-induced plasma membrane permeability and cytotoxicity in U87-MG human malignant glioblastoma cells. Onishi H; Jimi S; Tsugu H; Lee S; Fukushima T Anticancer Res; 2006; 26(6A):4033-41. PubMed ID: 17195454 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins. Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354 [TBL] [Abstract][Full Text] [Related]
20. Structural and functional characterization of a recombinant sticholysin I (rSt I) from the sea anemone Stichodactyla helianthus. Pazos F; Valle A; Martínez D; Ramírez A; Calderón L; Pupo A; Tejuca M; Morera V; Campos J; Fando R; Dyszy F; Schreier S; Horjales E; Alvarez C; Lanio ME; Lissi E Toxicon; 2006 Dec; 48(8):1083-94. PubMed ID: 17067649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]